Join us for the ASFA 2019 State of the Science Conference on Extracorporeal Photopheresis (ECP) to learn about scientific advances with substantial promise for translation into broadened clinical applications, personalized tailoring of the therapy, and more direct monitoring of treatment efficacy.
This groundbreaking, one-day conference, will highlight the most up-to-date, scientifically-based concepts key to the mechanism(s) underlying ECP’s antigen-specific immunogenic and tolerogenic efficacy. Field experts will address the potential to test these principles in the treatment of a broad spectrum of immunogenic cancers (including solid tumors, such as melanoma and ovarian carcinoma) and auto-reactive immunologic disorders (including haplotype mismatched stem cell transplants and allogeneic organ transplants). The special capacity of psoralen to augment the immunogenicity and tolerogenicity of ECP-processed cancer cells and of ECP-activated platelets to physiologically induce therapeutic dendritic antigen processing cells (DC) will be elucidated. Development and execution of derived trials will be described. Meeting participants will then partner with the leaders of the American Council on ECP (ACE) in break-out sessions to discuss the planning of the next generation of innovative trials. Please register early for this exciting conference and choose two working groups that best suit your interests. We look forward to seeing you in Portland!
Join us on Tuesday, May 14th, 2019 at the Hilton Portland in Portland, Oregon.
ASFA Member: $150
Yan Yun Wu